Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs

XJ Wang, Y Li, L Luo, H Wang, Z Chi, A Xin, X Li… - … Biology and Medicine, 2014 - Elsevier
… Our study showed that oxaliplatin exerts protection against the cytotoxicity of anticancer
drugs via Nrf2, indicating an important role of Nrf2 in oxaliplatin-based chemotherapy. …

Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble …

M Ishtikhar, MV Khan, S Khan… - Journal of …, 2016 - Taylor & Francis
Full article: Biophysical and molecular docking insight into interaction mechanism and
thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble …

Oxaliplatin Pt (IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents

G Thiabaud, G He, S Sen, KA Shelton… - Proceedings of the …, 2020 - National Acad Sciences
oxaliplatin activity was lost after 14 h on incubation with albumin, whereas the anticancer
activity of 3 was maintained over a full 24 h of incubation in the presence of albumin (Fig. 3B…

Structure–activity relationships of triple-action platinum (IV) Prodrugs with albumin-binding properties and immunomodulating ligands

P Fronik, I Poetsch, A Kastner, T Mendrina… - Journal of Medicinal …, 2021 - ACS Publications
… Binding to serum albumin represents one of the most efficient … cytotoxic properties of
oxaliplatin, the anticancer activity of our … With regard to blood plasma, treatment with all maleimide …

Novel adducts of the anticancer drug oxaliplatin with glutathione and redox reactions with glutathione disulfide

S Fakih, VP Munk, MA Shipman… - European Journal of …, 2003 - Wiley Online Library
… present as metabolites in the blood plasma and urine.[31] In … Such redox chemistry of
platinum() anticancer drugs has … can cleave disulfide bonds in human serum albumin,[36] and …

Oxaliplatin: a review of evolving concepts

S Mani, MA Graham, DB Bregman, P Ivy… - Cancer …, 2002 - Taylor & Francis
… modifying/alkylating agents (cisplatin and cyclophosphamide) Citation[[65]]… oxaliplatin
demonstrates additive/synergistic activity in combination with many standard anticancer agents in …

Characterization of intact hemoglobin and oxaliplatin interaction by nanoelectrospray ionization tandem mass spectrometry

J Peng, R Mandal, M Sawyer, XF Li - Clinical chemistry, 2005 - academic.oup.com
… of oxaliplatin (almost 85%–88%) in blood plasma is bound to … of oxaliplatin to serum
albumin is suspected to reduce its anticancer potential (12), and the accumulation of oxaliplatin in …

Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models

S Göschl, E Schreiber-Brynzak, V Pichler, K Cseh… - Metallomics, 2017 - academic.oup.com
drug oxaliplatin have been shown to be potent anticancer compounds maintaining some
central properties of the parental drug … among the most successful anticancer drugs. However, …

Albumin-based cancer therapeutics for intraperitoneal drug delivery: A review

L Van de Sande, S Cosyns, W Willaert, W Ceelen - Drug Delivery, 2020 - Taylor & Francis
drugs formulated by Abraxis Bioscience, many other labs have experimented with the delivery
of hydrophobic small-molecule anticancer drugs using albumin … -human serum albumin (…

Development of Anticancer Activity of the Pt(II) Complex with N-Heterocyclic Amine: Its In Vitro Pharmacokinetics with Thiol and Thio-Ethers, DNA and BSA Binding …

A Pan, I Mitra, S Mukherjee, S Ghosh… - ACS Applied Bio …, 2021 - ACS Publications
… to the recognized anticancer drugs such as cisplatin, carboplatin, and oxaliplatin. Cell cycle
… such as bovine serum albumin (similar to HSA, human serum albumin) was performed by …